“Comparing Thyroid Biomarkers And The Quality Of Nuclear Scan Images Of Patients With Thyroid Cancer After Levothyroxine Withdrawal Or Receiving Thyrotropin Alfa: A Retrospective Study”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 2024–2031, Dec. 2022, doi: 10.47750/pnr.2022.13.04.275.